Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity

被引：66

作者：

El Newahie, Aliya M. S. ^{[1
]}

Ismail, Nasser S. M. ^{[2
]}

Abou El Ella, Dalal A. ^{[3
]}

Abouzid, Khaled A. M. ^{[3
]}

机构：

[1] October Univ Modern Sci & Arts MSA, Dept Organ Pharmaceut Chem, Fac Pharm, Cairo, Egypt

[2] Future Univ, Dept Pharmaceut Chem, Fac Pharmaceut Sci & Pharmaceut Ind, Cairo, Egypt

[3] Ain Shams Univ, Dept Pharmaceut Chem, Fac Pharm, Cairo 11566, Egypt

来源：

ARCHIV DER PHARMAZIE | 2016年 / 349卷 / 05期

关键词：

Anticancer; Kinase inhibitors; Quinoxalines; SAR; Synthetic strategies; GROWTH-FACTOR RECEPTOR; ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; ONE-POT SYNTHESIS; BIOLOGICAL EVALUATION; INHIBITORY-ACTIVITY; POLYCYTHEMIA-VERA; CLINICAL-PROGRESS; FLT3; INHIBITORS; CDK4;

D O I：

10.1002/ardp.201500468

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Quinoxaline derivatives, also called benzopyrazines, are an important class of heterocyclic compounds. Quinoxalines have drawn great attention due to their wide spectrum of biological activities. They are considered as an important basis for anticancer drugs due to their potential activity as protein kinase inhibitors. In this review, we focus on the chemistry of the quinoxaline derivatives, the strategies for their synthesis, their potential activities against various tyrosine kinases, and on the structure-activity relationship studies reported to date.

引用

页码：309 / 326

页数：18

共 115 条

[81] Vascular endothelial growth factor family of ligands and receptors: Review [J].

Otrock, Zaher K. ;

Makarem, Jawad A. ;

Shamseddine, Ali I. .

BLOOD CELLS MOLECULES AND DISEASES, 2007, 38 (03) :258-268

[82] Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor [J].

Palmer, BD ;

Smaill, JB ;

Boyd, M ;

Boschelli, DH ;

Doherty, AM ;

Hamby, JM ;

Khatana, SS ;

Kramer, JB ;

Kraker, AJ ;

Panek, RL ;

Lu, GH ;

Dahring, TK ;

Winters, RT ;

Showalter, HDH ;

Denny, WA .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (27) :5457-5465

[83] Imidazo[1,2-a]quinoxalines:: synthesis and cyclic nucleotide phosphodiesterase inhibitory activity [J].

Parra, S ;

Laurent, F ;

Subra, G ;

Deleuze-Masquefa, C ;

Benezech, V ;

Fabreguettes, JR ;

Vidal, JP ;

Pocock, T ;

Elliott, K ;

Small, R ;

Escale, R ;

Michel, A ;

Chapat, JP ;

Bonnet, PA .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (03) :255-264

[84]

Patidar A. K., 2011, International Journal of PharmTech Research, V3, P386

[85] Mechanisms of cyclin-dependent kinase regulation: Structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors [J].

Pavletich, NP .

JOURNAL OF MOLECULAR BIOLOGY, 1999, 287 (05) :821-828

[86] Specificity in signal transduction: From phosphotyrosine-SH2 domain interactions to complex cellular systems [J].

Pawson, T .

CELL, 2004, 116 (02) :191-203

[87] Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase [J].

Porter, John ;

Lumb, Simon ;

Lecomte, Fabien ;

Reuberson, James ;

Foley, Anne ;

Calmiano, Mark ;

le Riche, Kelly ;

Edwards, Helen ;

Delgado, Jean ;

Franklin, Richard J. ;

Gascon-Simorte, Jose M. ;

Maloney, Alison ;

Meier, Christoph ;

Batchelor, Mark .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) :397-400

[88] DABCO-Catalyzed Oxidation of Deoxybenzoins to Benzils with Air and One-Pot Synthesis of Quinoxalines [J].

Qi, Chaorong ;

Jiang, Huanfeng ;

Huang, Liangbin ;

Chen, Zhengwang ;

Chen, Huoji .

SYNTHESIS-STUTTGART, 2011, (03) :387-396

[89]

Qiu H. H. W. K. M., 2012, BIOORGAN MED CHEM, V20, P2010

[90] The protein tyrosine kinase family of the human genome [J].

Robinson, DR ;

Wu, YM ;

Lin, SF .

ONCOGENE, 2000, 19 (49) :5548-5557

← 3 4 5 6 7 8 9 10 11 12 →